Canada markets open in 6 hours 59 minutes

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
23.70-3.00 (-11.25%)
At close: 04:00PM EST
24.50 +0.80 (+3.35%)
After hours: 07:51PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.25B
Enterprise Value 1.18B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)29.25
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -9.97

Trading Information

Stock Price History

Beta (5Y Monthly) 2.22
52-Week Change 3-68.63%
S&P500 52-Week Change 314.07%
52 Week High 378.00
52 Week Low 319.38
50-Day Moving Average 334.42
200-Day Moving Average 343.94

Share Statistics

Avg Vol (3 month) 3603.3k
Avg Vol (10 day) 3688.48k
Shares Outstanding 537.69M
Implied Shares Outstanding 6N/A
Float 829.63M
% Held by Insiders 121.42%
% Held by Institutions 148.77%
Shares Short (Dec. 30, 2021) 43.43M
Short Ratio (Dec. 30, 2021) 47.04
Short % of Float (Dec. 30, 2021) 415.36%
Short % of Shares Outstanding (Dec. 30, 2021) 49.11%
Shares Short (prior month Nov. 29, 2021) 43.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.76%
Return on Equity (ttm)-141.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -119.74M
Net Income Avi to Common (ttm)-125.59M
Diluted EPS (ttm)-3.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)114.62M
Total Cash Per Share (mrq)3.04
Total Debt (mrq)50.05M
Total Debt/Equity (mrq)117.17
Current Ratio (mrq)4.66
Book Value Per Share (mrq)1.13

Cash Flow Statement

Operating Cash Flow (ttm)-99.94M
Levered Free Cash Flow (ttm)-52.25M